Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,155,075
-$26,027,097 QoQ
Shares Held
5,863,654
+2.6% QoQ
Ownership
1.68%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. NUVB ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,155,075 | 5,863,654 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $51,182,172 | 5,712,296 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $21,784,693 | 5,887,755 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $11,689,855 | 5,994,798 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $9,029,862 | 5,130,604 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,170,178 | 4,951,195 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,225,703 | 4,028,692 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,190,739 | 3,832,445 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $11,383,000 | 3,127,198 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,599,950 | 3,046,325 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,886,163 | 2,900,122 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,915,278 | 2,730,710 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,964,536 | 2,388,275 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,452,545 | 2,319,034 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,092,227 | 2,273,316 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,490,478 | 2,003,234 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,958,457 | 2,273,471 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $18,339,430 | 2,157,580 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $14,008,988 | 1,409,355 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,484,672 | 803,939 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,450,531 | 521,582 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||